Home › Calculator › CRIS Dividend Calculator 2026
CRIS Dividend DRIP Calculator 2026
577.03% YieldHealthcareCuris, Inc. · NASDAQ
Price: $0.35 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CRIS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CRIS snowball 📈
$10,000 in CRIS → $17040470361615566848.00M in 10 years · $1,419,798,912,473,629,700,000,000.00/month
About Curis, Inc. (CRIS) — Dividend Analysis 2026
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company’s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small-molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreements with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed three programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.
Compare CRIS with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CRIS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CRIS position with:
🌍 CRIS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CRIS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 577.03% | 574.23% | $57,703 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 490.48% | 487.68% | $49,048 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 461.62% | 458.82% | $46,162 / yr |
| 🇬🇧 UK ISA | 0% | 577.03% | 574.23% | $57,703 / yr |
| 🇬🇧 UK Taxable | 8.75% | 526.54% | 523.74% | $52,654 / yr |
| 🇨🇦 TFSA | 0% | 577.03% | 574.23% | $57,703 / yr |
| 🇨🇦 CA Taxable | 25% | 432.77% | 429.97% | $43,277 / yr |
| 🇦🇺 Super (pension) | 15% | 490.48% | 487.68% | $49,048 / yr |
| 🇦🇺 AU Taxable | 30% | 403.92% | 401.12% | $40,392 / yr |
| 🇩🇪 DE Taxable | 26.375% | 424.84% | 422.04% | $42,484 / yr |
| 🇫🇷 FR Taxable | 30% | 403.92% | 401.12% | $40,392 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CRIS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CRIS Dividend Payment Schedule
CRIS pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CRIS vs Healthcare Benchmarks
How CRIS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CRIS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CRIS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-07 | 6,800 | $5.29 | $36.0K | ||
| A-Award | 2026-07-07 | 6,800 | $5.29 | $36.0K | ||
| A-Award | 2026-07-07 | 6,800 | $5.29 | $36.0K | ||
| A-Award | 2026-07-07 | 6,800 | $5.29 | $36.0K | ||
| A-Award | 2026-07-07 | 6,800 | $5.29 | $36.0K | ||
| A-Award | 2026-07-07 | 48,285 | $5.29 | $255.4K | ||
| A-Award | 2026-07-07 | 48,285 | $5.29 | $255.4K | ||
| A-Award | 2026-07-07 | 110,090 | $5.29 | $582.4K | ||
| Buy | 2026-03-31 | 10,000 | $0.55 | $5.5K | ||
| C-Conversion | 2026-03-20 | 66,667 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CRIS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Curis, Inc. (CRIS) is currently trading at $0.35, trading near its 52-week low. The current dividend yield is 577.03% based on an annual payout of $2.00 per share.
CRIS (Curis, Inc.) — 577.03% Dividend Yield Analysis
Curis, Inc. (CRIS) is a healthcare stock currently trading at $0.35 with a dividend yield of 577.03%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (577.03%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.